AI Article Synopsis

  • The study looked at two boys with a type of leukemia called acute myeloid leukemia (AML) that had a specific chromosome problem (i(17)(q10)).
  • Both patients showed similar symptoms to another type of leukemia called acute promyelocytic leukemia (APL), but their treatment didn't work well.
  • The researchers found that the drugs they used (ATRA and arsenic) might not help much for these cases of AML that had the i(17)(q10) chromosome issue.

Article Abstract

Background: Chromosome i(17)(q10) abnormality is mainly associated with chronic myeloid leukemia (CML), myelodysplastic syndrome/myeloproliferative tumors (MDS/MPD), and acute myeloid leukemia (AML). The role of i(17)(q10) in AML is still unknown, the differences between AML and acute promyelocytic leukemia (APL)-like AML with i(17)(q10) need more research. This study aimed to investigate the clinical characteristics and laboratory evidence of 2 AML cases with i(17)(q10), similar to APL phenotype.

Case Summary: Both pediatric patients were males; case 1 had newly diagnosed AML, and case 2 showed relapsed tumor after 1 year of drug withdrawal. Bone marrow cell morphology, chromosome karyotype analysis, Fully-instrumented submersible housing test, immunological assays, molecular biological methods, and blood tumor panoramic gene test were performed. All-trans retinoic acid (ATRA) combined with arsenic acid (As2O3) were used in the first course of treatment. Bone marrow was dominated by abnormal promyelocytic granulocytes. Karyotype test revealed i(17)(q10) isochromosome. Immunological phenotype mainly included positive expressions of CD9, CD13, CD33, and CD38. Case 1 suffered intracranial hemorrhage after re-chemotherapy and died on D162. For case 2, on D145 and D265, bone marrow promyelocytic granulocytes accounted for 2%. Flow cytometric residual lesion detection showed no abnormal immunophenotype cells. The copy number of WT1 gene in two cases were 1087 and 1010, respectively, and the expression rates were 55.29% and 59.5%, respectively.

Conclusion: ATRA, As2O3, and chemotherapy may be ineffective in treating APL-like AML with i(17)(q10) but without t(15;17) and PML-RARA fusion gene.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210900PMC
http://dx.doi.org/10.12998/wjcc.v10.i16.5446DOI Listing

Publication Analysis

Top Keywords

myeloid leukemia
12
bone marrow
12
acute myeloid
8
acute promyelocytic
8
promyelocytic leukemia
8
apl-like aml
8
aml i17q10
8
promyelocytic granulocytes
8
i17q10
7
aml
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!